Ann E. Taylor, MD Joins the TB Alliance Board of Directors
NEW YORK (August, 15, 2024)—TB Alliance is honored to appoint Ann Taylor, MD to its Board of Directors. Welcoming Dr. […]
Uncategorized
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
MANILA (25 March 2024)—TB Alliance’s new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today in Manila, with funding
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
CANBERRA (25 March 2024)—The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17
Commitment, Innovation and Action are Needed to End TB — On World TB Day, We Reaffirm our Dedication to all Impacted by Tuberculosis
NEW YORK (March 24, 2024)—Today is World TB Day, the anniversary of when, in 1882, Dr. Robert Koch announced his
Funding for TB and Neglected Diseases Backslides
NEW YORK (January 31, 2024)—The 2023 G-FINDER Report, released today, reveals that funding for neglected disease R&D fell by 10%
Uncategorized
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug
Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that
High Cure Rate with Drug-Resistant TB Regimen: Results of Operational Research in Central and Southeast Asia
Indonesia, Kyrgyzstan, Philippines, Ukraine, Uzbekistan, and Viet Nam presented results of LIFT-TB operational research program at the Union Conference on
TB Alliance Applauds Macleods’ Launch of a Key Component of WHO-Recommended Drug-Resistant TB Treatment Regimen
NEW YORK (November 13, 2023)—Indian pharmaceutical company Macleods has become the second manufacturer to launch pretomanid, a new medicine and
New Drug-Resistant TB Treatments Reach Patients in Pakistan as Association for Social Development Accelerates Pilot Implementation
ISLAMABAD and PRETORIA (9 November 2023)—The Association for Social Development (ASD) has registered 206 participants with drug-resistant tuberculosis (DR-TB) in
New WHO Global TB Report Shows Recovery in Effort to Combat TB, But Stronger Investments are Needed to Help Reach UN Goals
“We are heartened to see that progress against tuberculosis (TB) has started to rebound after several years of increased numbers